INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $619,360 | -15.8% | 56,000 | +2.2% | 0.01% | -25.0% |
| Q1 2023 | $735,964 | -8.7% | 54,800 | -16.0% | 0.01% | 0.0% |
| Q4 2022 | $806,524 | +2.3% | 65,200 | +15.4% | 0.01% | -11.1% |
| Q3 2022 | $788,175 | +27.7% | 56,500 | +49.1% | 0.01% | +50.0% |
| Q1 2022 | $617,000 | +4.9% | 37,900 | +5.0% | 0.01% | +50.0% |
| Q4 2021 | $588,000 | +9.7% | 36,100 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $536,000 | -10.8% | 36,100 | +19.9% | 0.01% | -16.7% |
| Q2 2021 | $601,000 | +45.5% | 30,100 | +68.2% | 0.01% | +50.0% |
| Q1 2021 | $413,000 | +32.8% | 17,900 | +42.1% | 0.00% | +33.3% |
| Q4 2020 | $311,000 | +44.0% | 12,600 | +180.0% | 0.00% | 0.0% |
| Q2 2020 | $216,000 | -32.7% | 4,500 | -11.8% | 0.00% | -25.0% |
| Q1 2020 | $321,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |